Bausch Health Companies Inc. Investing Cash Flow
Bausch Health Companies Inc. (BHC) reported Investing Cash Flow of -$232.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-07-30
- Bausch Health Companies Inc. net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was -$93.00M.
- Bausch Health Companies Inc. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was -$139.00M.
- Bausch Health Companies Inc. net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was -$282.00M.
- Bausch Health Companies Inc. net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was -$83.00M.
- Bausch Health Companies Inc. net cash provided by (used in) investing activities for fiscal 2025 was -$595.00M.
- Bausch Health Companies Inc. net cash provided by (used in) investing activities for fiscal 2024 was -$454.00M.
- Bausch Health Companies Inc. net cash provided by (used in) investing activities for fiscal 2023 was -$2.15B.
- Bausch Health Companies Inc. net cash provided by (used in) investing activities for fiscal 2022 was -$303.00M, a 174.08% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 6 month as first filed | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 9 month as first filed | Net Cash Provided by (Used in) Investing Activities 12 month | Net Cash Provided by (Used in) Investing Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$93.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | -$232.00M 10-Q · filed 2026-07-30 | -$514.00M derived: sum of 3 quarters · filed 2026-07-30 | -$597.00M derived: sum of 4 quarters · filed 2026-07-30 | |||
| 2026-03-31 | -$139.00M 10-Q · filed 2026-04-30 | -$421.00M derived: sum of 2 quarters · filed 2026-04-30 | -$504.00M derived: sum of 3 quarters · filed 2026-04-30 | -$604.00M derived: sum of 4 quarters · filed 2026-07-30 | |||
| 2025-12-31 | -$282.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | -$365.00M derived: sum of 2 quarters · filed 2026-02-19 | -$465.00M derived: sum of 3 quarters · filed 2026-07-30 | -$595.00M 10-K · filed 2026-02-19 | |||
| 2025-09-30 | -$83.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | -$183.00M derived: sum of 2 quarters · filed 2026-07-30 | -$313.00M 10-Q · filed 2025-10-30 | -$513.00M derived: sum of 4 quarters · filed 2026-07-30 | |||
| 2025-06-30 | -$100.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | -$230.00M 10-Q · filed 2026-07-30 | -$430.00M derived: sum of 3 quarters · filed 2026-07-30 | -$532.00M derived: sum of 4 quarters · filed 2026-07-30 | |||
| 2025-03-31 | -$130.00M 10-Q · filed 2026-04-30 | -$330.00M derived: sum of 2 quarters · filed 2026-04-30 | -$432.00M derived: sum of 3 quarters · filed 2026-04-30 | -$511.00M derived: sum of 4 quarters · filed 2026-04-30 | |||
| 2024-12-31 | -$200.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | -$302.00M derived: sum of 2 quarters · filed 2026-02-19 | -$381.00M derived: sum of 3 quarters · filed 2026-02-19 | -$454.00M 10-K · filed 2026-02-19 | |||
| 2024-09-30 | -$102.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | -$181.00M derived: sum of 2 quarters · filed 2025-10-30 | -$254.00M 10-Q · filed 2025-10-30 | -$402.00M derived: sum of 4 quarters · filed 2026-02-19 | |||
| 2024-06-30 | -$79.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | -$152.00M 10-Q · filed 2025-07-31 | -$300.00M derived: sum of 3 quarters · filed 2026-02-19 | -$2.19B derived: sum of 4 quarters · filed 2026-02-19 | |||
| 2024-03-31 | -$73.00M 10-Q · filed 2025-05-01 | -$221.00M derived: sum of 2 quarters · filed 2026-02-19 | -$2.11B derived: sum of 3 quarters · filed 2026-02-19 | -$2.14B derived: sum of 4 quarters · filed 2026-02-19 | |||
| 2023-12-31 | -$148.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | -$2.04B derived: sum of 2 quarters · filed 2026-02-19 | -$2.07B derived: sum of 3 quarters · filed 2026-02-19 | -$2.15B 10-K · filed 2026-02-19 | |||
| 2023-09-30 | -$1.89B derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | -$1.92B derived: sum of 2 quarters · filed 2024-10-31 | -$2.00B 10-Q · filed 2024-10-31 | -$2.13B derived: sum of 4 quarters · filed 2025-02-20 | |||
| 2023-06-30 | -$30.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | -$108.00M 10-Q · filed 2024-08-01 | -$244.00M derived: sum of 3 quarters · filed 2025-02-20 | -$297.00M derived: sum of 4 quarters · filed 2025-02-20 | |||
| 2023-03-31 | -$78.00M 10-Q · filed 2024-05-02 | -$214.00M derived: sum of 2 quarters · filed 2025-02-20 | -$267.00M derived: sum of 3 quarters · filed 2025-02-20 | -$325.00M derived: sum of 4 quarters · filed 2025-02-20 | |||
| 2022-12-31 | -$136.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | -$189.00M derived: sum of 2 quarters · filed 2025-02-20 | -$247.00M derived: sum of 3 quarters · filed 2025-02-20 | -$303.00M 10-K · filed 2025-02-20 | |||
| 2022-09-30 | -$53.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | -$111.00M derived: sum of 2 quarters · filed 2023-11-02 | -$167.00M 10-Q · filed 2023-11-02 | -$247.00M derived: sum of 4 quarters · filed 2024-02-22 | |||
| 2022-06-30 | -$58.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$114.00M 10-Q · filed 2023-08-03 | -$194.00M derived: sum of 3 quarters · filed 2024-02-22 | $394.00M derived: sum of 4 quarters · filed 2024-02-22 | |||
| 2022-03-31 | -$56.00M 10-Q · filed 2023-05-04 | -$136.00M derived: sum of 2 quarters · filed 2024-02-22 | $452.00M derived: sum of 3 quarters · filed 2024-02-22 | $409.00M derived: sum of 4 quarters · filed 2024-02-22 | |||
| 2021-12-31 | -$80.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $508.00M derived: sum of 2 quarters · filed 2024-02-22 | $465.00M derived: sum of 3 quarters · filed 2024-02-22 | $409.00M 10-K · filed 2024-02-22 | |||
| 2021-09-30 | $588.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $545.00M derived: sum of 2 quarters · filed 2022-11-03 | $489.00M 10-Q · filed 2022-11-03 | $405.00M derived: sum of 4 quarters · filed 2023-02-23 | |||
| 2021-06-30 | -$43.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$99.00M 10-Q · filed 2022-08-09 | -$183.00M derived: sum of 3 quarters · filed 2023-02-23 | -$253.00M derived: sum of 4 quarters · filed 2023-02-23 | |||
| 2021-03-31 | -$56.00M 10-Q · filed 2022-05-10 | -$140.00M derived: sum of 2 quarters · filed 2023-02-23 | -$210.00M derived: sum of 3 quarters · filed 2023-02-23 | -$277.00M derived: sum of 4 quarters · filed 2023-02-23 | |||
| 2020-12-31 | -$84.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | -$154.00M derived: sum of 2 quarters · filed 2023-02-23 | -$221.00M derived: sum of 3 quarters · filed 2023-02-23 | -$261.00M 10-K · filed 2023-02-23 | |||
| 2020-09-30 | -$70.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | -$137.00M derived: sum of 2 quarters · filed 2021-11-02 | -$177.00M 10-Q · filed 2021-11-02 | -$262.00M derived: sum of 4 quarters · filed 2022-05-11 | |||
| 2020-06-30 | -$67.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | -$107.00M 10-Q · filed 2021-08-03 | -$192.00M derived: sum of 3 quarters · filed 2022-05-11 | -$265.00M derived: sum of 4 quarters · filed 2022-05-11 | |||
| 2020-03-31 | -$40.00M 10-Q · filed 2021-05-04 | -$125.00M derived: sum of 2 quarters · filed 2022-05-11 | -$198.00M derived: sum of 3 quarters · filed 2022-05-11 | -$256.00M derived: sum of 4 quarters · filed 2022-05-11 | |||
| 2019-12-31 | -$85.00M derived: 8-K 12 month − 10-Q 9 month · filed 2022-05-11 | -$158.00M derived: sum of 2 quarters · filed 2022-05-11 | -$216.00M derived: sum of 3 quarters · filed 2022-05-11 | -$419.00M 8-K · filed 2022-05-11 | |||
| 2019-09-30 | -$73.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-03 | -$131.00M derived: sum of 2 quarters · filed 2020-11-03 | -$334.00M 10-Q · filed 2020-11-03 | -$396.00M derived: sum of 4 quarters · filed 2021-05-04 | |||
| 2019-06-30 | -$58.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$261.00M 10-Q · filed 2020-08-06 | -$323.00M derived: sum of 3 quarters · filed 2021-05-04 | -$318.00M derived: sum of 4 quarters · filed 2021-05-04 | |||
| 2019-03-31 | -$203.00M 10-Q · filed 2020-05-07 | -$265.00M derived: sum of 2 quarters · filed 2021-05-04 | -$260.00M derived: sum of 3 quarters · filed 2021-05-04 | -$351.00M derived: sum of 4 quarters · filed 2021-05-04 | |||
| 2018-12-31 | -$62.00M derived: 8-K 12 month − 10-Q 9 month · filed 2021-05-04 | -$57.00M derived: sum of 2 quarters · filed 2021-05-04 | -$148.00M derived: sum of 3 quarters · filed 2021-05-04 | -$196.00M 8-K · filed 2021-05-04 | |||
| 2018-09-30 | $5.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-04 | -$86.00M derived: sum of 2 quarters · filed 2019-11-04 | -$134.00M 10-Q · filed 2019-11-04 | -$44.00M derived: sum of 4 quarters · filed 2020-02-19 | |||
| 2018-06-30 | -$91.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | -$139.00M 10-Q · filed 2019-08-06 | -$49.00M derived: sum of 3 quarters · filed 2020-02-19 | $820.00M derived: sum of 4 quarters · filed 2020-02-19 | |||
| 2018-03-31 | -$48.00M 10-Q · filed 2019-05-06 | $42.00M derived: sum of 2 quarters · filed 2020-02-19 | $911.00M derived: sum of 3 quarters · filed 2020-02-19 | $1.69B derived: sum of 4 quarters · filed 2020-02-19 | |||
| 2017-12-31 | $90.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-19 | $959.00M derived: sum of 2 quarters · filed 2020-02-19 | $1.74B derived: sum of 3 quarters · filed 2020-02-19 | $2.89B 10-K · filed 2020-02-19 | |||
| 2017-09-30 | $869.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $1.65B derived: sum of 2 quarters · filed 2018-11-06 | $2.80B 10-Q · filed 2018-11-06 | $2.80B derived: sum of 4 quarters · filed 2019-02-20 | |||
| 2017-06-30 | $780.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $1.93B 10-Q · filed 2018-08-07 | $1.93B derived: sum of 3 quarters · filed 2019-02-20 | $1.86B derived: sum of 4 quarters · filed 2019-02-20 | |||
| 2017-03-31 | $1.15B 10-Q · filed 2018-05-08 | $1.15B derived: sum of 2 quarters · filed 2019-02-20 | $1.08B derived: sum of 3 quarters · filed 2019-02-20 | $1.14B derived: sum of 4 quarters · filed 2019-02-20 | |||
| 2016-12-31 | $6.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-20 | -$63.00M derived: sum of 2 quarters · filed 2019-02-20 | -$13.00M derived: sum of 3 quarters · filed 2019-02-20 | -$125.00M 10-K · filed 2019-02-20 | |||
| 2016-09-30 | -$69.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | -$19.00M derived: sum of 2 quarters · filed 2017-11-07 | -$131.00M 10-Q · filed 2017-11-07 | -$131.40M 10-Q · filed 2016-11-09 | -$1.67B derived: sum of 4 quarters · filed 2018-08-10 | ||
| 2016-06-30 | $50.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | -$62.00M 10-Q · filed 2017-08-08 | -$62.10M 10-Q · filed 2016-08-09 | -$1.60B derived: sum of 3 quarters · filed 2018-08-10 | -$1.75B derived: sum of 4 quarters · filed 2018-08-10 | ||
| 2016-03-31 | -$112.00M 10-Q · filed 2017-05-09 | -$1.65B derived: sum of 2 quarters · filed 2018-08-10 | -$1.80B derived: sum of 3 quarters · filed 2018-08-10 | -$4.45B derived: sum of 4 quarters · filed 2018-08-10 | |||
| 2015-12-31 | -$1.54B derived: 8-K 12 month − 10-Q 9 month · filed 2018-08-10 | -$1.69B derived: sum of 2 quarters · filed 2018-08-10 | -$4.34B derived: sum of 3 quarters · filed 2018-08-10 | -$15.58B 8-K · filed 2018-08-10 | -$15.58B 10-K · filed 2016-04-29 | ||
| 2015-09-30 | -$156.20M 10-Q · filed 2015-10-26 | -$2.80B derived: sum of 2 quarters · filed 2015-10-26 | -$14.04B 10-Q · filed 2016-11-09 | -$14.25B derived: sum of 4 quarters · filed 2017-03-01 | |||
| 2015-06-30 | -$2.65B 10-Q · filed 2015-07-28 | -$13.89B 10-Q · filed 2016-08-09 | -$14.09B derived: sum of 3 quarters · filed 2017-03-01 | -$13.34B derived: sum of 4 quarters · filed 2017-03-01 | |||
| 2015-03-31 | -$11.24B 10-Q · filed 2016-06-07 | -$11.45B derived: sum of 2 quarters · filed 2017-03-01 | -$10.69B derived: sum of 3 quarters · filed 2017-03-01 | -$10.96B derived: sum of 4 quarters · filed 2017-03-01 | |||
| 2014-12-31 | -$205.80M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $550.50M derived: sum of 2 quarters · filed 2017-03-01 | $284.10M derived: sum of 3 quarters · filed 2017-03-01 | -$100.00M 10-K · filed 2017-03-01 | -$99.70M 10-K · filed 2015-02-25 | ||
| 2014-09-30 | $756.30M 10-Q · filed 2015-10-26 | $489.90M derived: sum of 2 quarters · filed 2015-10-26 | $105.80M 10-Q · filed 2015-10-26 | ||||
| 2014-06-30 | -$266.40M 10-Q · filed 2015-07-28 | -$650.50M 10-Q · filed 2015-07-28 | |||||
| 2014-03-31 | -$384.10M 10-Q · filed 2015-04-30 | ||||||
| 2013-12-31 | -$5.38B 10-K · filed 2016-04-29 | ||||||
| 2012-12-31 | -$2.97B 10-K · filed 2015-02-25 | ||||||
| 2011-06-30 | -$62.50M 10-Q · filed 2011-08-08 | -$887.83M 10-Q · filed 2011-08-08 | -$921.03M derived: sum of 3 quarters · filed 2011-08-08 | -$605.66M derived: sum of 4 quarters · filed 2011-08-08 | |||
| 2011-03-31 | -$825.33M 10-Q · filed 2011-05-10 | -$858.53M derived: sum of 2 quarters · filed 2011-05-10 | -$543.16M derived: sum of 3 quarters · filed 2011-05-10 | -$552.51M derived: sum of 4 quarters · filed 2011-08-08 | |||
| 2010-12-31 | -$33.20M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-28 | $282.17M derived: sum of 2 quarters · filed 2011-02-28 | $272.82M derived: sum of 3 quarters · filed 2011-08-08 | $228.94M 10-K · filed 2011-02-28 | |||
| 2010-09-30 | $315.37M 10-Q · filed 2010-11-05 | $306.01M derived: sum of 2 quarters · filed 2011-08-08 | $262.13M 10-Q · filed 2010-11-05 | $267.67M derived: sum of 4 quarters · filed 2011-08-08 | |||
| 2010-06-30 | -$9.35M 10-Q · filed 2011-08-08 | -$53.23M 10-Q · filed 2011-08-08 | -$47.70M derived: sum of 3 quarters · filed 2011-08-08 | -$52.21M derived: sum of 4 quarters · filed 2011-08-08 | |||
| 2010-03-31 | -$43.88M 10-Q · filed 2011-05-10 | -$38.34M derived: sum of 2 quarters · filed 2011-05-10 | -$42.86M derived: sum of 3 quarters · filed 2011-05-10 | -$779.61M derived: sum of 4 quarters · filed 2011-05-10 | |||
| 2009-12-31 | $5.54M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-28 | $1.02M derived: sum of 2 quarters · filed 2011-02-28 | -$735.73M derived: sum of 3 quarters · filed 2011-02-28 | -$742.77M 10-K · filed 2011-02-28 | |||
| 2009-09-30 | -$4.51M 10-Q · filed 2010-11-05 | -$741.27M derived: sum of 2 quarters · filed 2010-11-05 | -$748.31M 10-Q · filed 2010-11-05 | ||||
| 2009-06-30 | -$736.75M 10-Q · filed 2010-08-06 | -$743.79M 10-Q · filed 2010-08-06 | |||||
| 2008-12-31 | -$107.83M 10-K · filed 2011-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 |